Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

Highlights

  • Highlights
    Highlights of This Issue
    Mol Cancer Ther February 1 2011 10 (2) 219-219;

Therapeutic Discovery

  • Therapeutic Discovery
    Antisense Inhibition of Survivin Expression as a Cancer Therapeutic
    Rosa A. Carrasco, Nancy B. Stamm, Eric Marcusson, George Sandusky, Philip Iversen and Bharvin K.R. Patel
    Mol Cancer Ther February 1 2011 10 (2) 221-232; DOI:10.1158/1535-7163.MCT-10-0756

  • Therapeutic Discovery
    Spliceosome-Mediated RNA Trans-Splicing Facilitates Targeted Delivery of Suicide Genes to Cancer Cells
    Christina Gruber, Iris K. Gratz, Eva M. Murauer, Elisabeth Mayr, Ulrich Koller, Leena Bruckner-Tuderman, Guerrino Meneguzzi, Helmut Hintner and Johann W. Bauer
    Mol Cancer Ther February 1 2011 10 (2) 233-241; DOI:10.1158/1535-7163.MCT-10-0669

  • Therapeutic Discovery
    A Robust High-Content Imaging Approach for Probing the Mechanism of Action and Phenotypic Outcomes of Cell-Cycle Modulators
    Jeffrey J. Sutherland, Jonathan Low, Wayne Blosser, Michele Dowless, Thomas A. Engler and Louis F. Stancato
    Mol Cancer Ther February 1 2011 10 (2) 242-254; DOI:10.1158/1535-7163.MCT-10-0720

  • Therapeutic Discovery
    Anticancer Activity of a Combination of Cisplatin and Fisetin in Embryonal Carcinoma Cells and Xenograft Tumors
    Rakshamani Tripathi, Tanmoy Samadder, Sarika Gupta, Avadhesha Surolia and Chandrima Shaha
    Mol Cancer Ther February 1 2011 10 (2) 255-268; DOI:10.1158/1535-7163.MCT-10-0606

  • Therapeutic Discovery
    p53R2 Inhibits the Proliferation of Human Cancer Cells in Association with Cell-Cycle Arrest
    Keqiang Zhang, Jun Wu, Xiwei Wu, Xiaochen Wang, Yan Wang, Ning Zhou, Mei-ling Kuo, Xiyong Liu, Bingsen Zhou, Lufen Chang, David Ann and Yun Yen
    Mol Cancer Ther February 1 2011 10 (2) 269-278; DOI:10.1158/1535-7163.MCT-10-0728

Preclinical Development

  • Preclinical Development
    Interpreting Mammalian Target of Rapamycin and Cell Growth Inhibition in a Genetically Engineered Mouse Model of Nf1-Deficient Astrocytes
    Sutapa Banerjee, Scott M. Gianino, Feng Gao, Uwe Christians and David H. Gutmann
    Mol Cancer Ther February 1 2011 10 (2) 279-291; DOI:10.1158/1535-7163.MCT-10-0654

  • Preclinical Development
    Low-Dose Fractionated Radiation Potentiates the Effects of Cisplatin Independent of the Hyper-Radiation Sensitivity in Human Lung Cancer Cells
    Seema Gupta, Tulay Koru-Sengul, Susanne M. Arnold, Gayathri R. Devi, Mohammed Mohiuddin and Mansoor M. Ahmed
    Mol Cancer Ther February 1 2011 10 (2) 292-302; DOI:10.1158/1535-7163.MCT-10-0630

  • Preclinical Development
    Silencing of Tubulin Binding Cofactor C Modifies Microtubule Dynamics and Cell Cycle Distribution and Enhances Sensitivity to Gemcitabine in Breast Cancer Cells
    Rouba Hage-Sleiman, Stéphanie Herveau, Eva-Laure Matera, Jean-Fabien Laurier and Charles Dumontet
    Mol Cancer Ther February 1 2011 10 (2) 303-312; DOI:10.1158/1535-7163.MCT-10-0568

  • Preclinical Development
    Chromatin Structure Predicts Epigenetic Therapy Responsiveness in Sarcoma
    Joslyn Mills, Todd Hricik, Sara Siddiqi and Igor Matushansky
    Mol Cancer Ther February 1 2011 10 (2) 313-324; DOI:10.1158/1535-7163.MCT-10-0724

  • Preclinical Development
    Ovarian Cancer Stem Cell–Like Side Populations Are Enriched Following Chemotherapy and Overexpress EZH2
    Siân Rizzo, Jenny M. Hersey, Paul Mellor, Wei Dai, Alessandra Santos-Silva, Daniel Liber, Louisa Luk, Ian Titley, Craig P Carden, Garry Box, David L. Hudson, Stanley B. Kaye and Robert Brown
    Mol Cancer Ther February 1 2011 10 (2) 325-335; DOI:10.1158/1535-7163.MCT-10-0788

  • Preclinical Development
    Knockdown of Oncogenic KRAS in Non–Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy
    Noriaki Sunaga, David S. Shames, Luc Girard, Michael Peyton, Jill E. Larsen, Hisao Imai, Junichi Soh, Mitsuo Sato, Noriko Yanagitani, Kyoichi Kaira, Yang Xie, Adi F. Gazdar, Masatomo Mori and John D. Minna
    Mol Cancer Ther February 1 2011 10 (2) 336-346; DOI:10.1158/1535-7163.MCT-10-0750

  • Preclinical Development
    Transcription Factor Stat5 Knockdown Enhances Androgen Receptor Degradation and Delays Castration-Resistant Prostate Cancer Progression In vivo
    Christian Thomas, Amina Zoubeidi, Hidetoshi Kuruma, Ladan Fazli, Francois Lamoureux, Eliana Beraldi, Brett P. Monia, A. Robert MacLeod, Joachim W. Thüroff and Martin E. Gleave
    Mol Cancer Ther February 1 2011 10 (2) 347-359; DOI:10.1158/1535-7163.MCT-10-0850

  • Preclinical Development
    Preclinical Pharmacology, Antitumor Activity, and Development of Pharmacodynamic Markers for the Novel, Potent AKT Inhibitor CCT128930
    Timothy A. Yap, Mike I. Walton, Lisa-Jane K. Hunter, Melanie Valenti, Alexis de Haven Brandon, Paul D. Eve, Ruth Ruddle, Simon P. Heaton, Alan Henley, Lisa Pickard, Gowri Vijayaraghavan, John J. Caldwell, Neil T. Thompson, Wynne Aherne, Florence I. Raynaud, Suzanne A. Eccles, Paul Workman, Ian Collins and Michelle D. Garrett
    Mol Cancer Ther February 1 2011 10 (2) 360-371; DOI:10.1158/1535-7163.MCT-10-0760

Back to top
PreviousNext
Molecular Cancer Therapeutics: 10 (2)
February 2011
Volume 10, Issue 2
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

Jump to

  • Highlights
  • Therapeutic Discovery
  • Preclinical Development
Advertisement
  • Most Cited
  • Most Read
Loading
  • CD137 Agonist mAb with Reduced Liver Toxicity
  • Truncated BRCA2 Contributes to PARPi Resistance
  • ERPAS to Predict Response to Endocrine Therapy
  • CDK8/19 Inhibitors Enhance NK-Cell–Mediated Cancer Therapy
  • Sialoglycan mAb for Cancer Immunotherapy
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement